Skip to main content

Blog

25 Years In Business

Posted by IBL-America on May 25th 2022

May of 2022 marks the 25th year IBL-America has been in business. This is an important milestone for a company like ours in an industry like this. IBL is striving for continuous improvement in our eng … read more

What is Ustekinumab?

May 18th 2022

What is Ustekinumab?The drug Ustekinumab (trade name Stelara®) is a humanized immunoglobulin G1 kappa monoclonal antibody that binds with high specificity to the p40 protein subunit used by both the I … read more

Lysozyme

May 12th 2022

Lysozyme ELISA for the detection of human lysozyme in serum, plasma or stool.The IBL-America Lysozyme Assay Kit (IB19131) provides researchers with a sensitive assay to measure levels of lysozyme in h … read more

It’s Medical Laboratory Professionals Week!

Apr 27th 2022

The Lab Week theme for 2022 is Giving the Gift of Health. The theme focuses on appreciating and celebrating diversity among laboratory professionals who give the gift of health by improving public hea … read more

Free Vitamin D and Kidney Disease

Apr 18th 2022

Vitamin D Binding Protein (VDBP) significantly decreases in case of kidney disease. This decrease leads to an increase in the free 25OH Vitamin D concentration, at constant total 25OH Vitamin D levels … read more